[Home]
[Full version]
Study likely spells end for anti-bleeding drug
May 14 ,Medicine & Health
(AP) -- An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit
www.ap.org .
[Home]
[Full version]